Cargando…

Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study

BACKGROUND: Cutaneous Leishmaniasis (CL) affects up to 5.000 people in Ecuador each year. L. guyanensis and L. braziliensis are the most common of the eight CL-causing Leishmania species. Earlier CL research concentrated on the easily accessible Pacific region. This study aims to describe the Leishm...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezemer, Jacob M., Freire-Paspuel, Byron P., Schallig, Henk D. F. H., de Vries, Henry J.C., Calvopiña, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258766/
https://www.ncbi.nlm.nih.gov/pubmed/37308815
http://dx.doi.org/10.1186/s12879-023-08377-8
_version_ 1785057534503026688
author Bezemer, Jacob M.
Freire-Paspuel, Byron P.
Schallig, Henk D. F. H.
de Vries, Henry J.C.
Calvopiña, Manuel
author_facet Bezemer, Jacob M.
Freire-Paspuel, Byron P.
Schallig, Henk D. F. H.
de Vries, Henry J.C.
Calvopiña, Manuel
author_sort Bezemer, Jacob M.
collection PubMed
description BACKGROUND: Cutaneous Leishmaniasis (CL) affects up to 5.000 people in Ecuador each year. L. guyanensis and L. braziliensis are the most common of the eight CL-causing Leishmania species. Earlier CL research concentrated on the easily accessible Pacific region. This study aims to describe the Leishmania species in Pacific and Amazon ecoregions, to analyze regional differences in CL patient clinical presentation, and to identify determinants of health-seeking delay. METHODS: All cases in this cross-sectional study were diagnosed using smear slide microscopy, PCR, or both. Cytochrome B gene sequencing was used to identify the causative Leishmania species in qPCR-positive samples. RESULTS: This study included 245 patients, with 154 (63%) infected in the Pacific region and 91 (37%) infected in the Amazon. Causative Leishmania species were identified in 135 patients (73% of qPCR positives). L. guyanensis was identified in 76% (102/135) of the samples and L. braziliensis in 19% (26/135). The Pacific region had a low prevalence of 6% (5/89) of L. braziliensis. For the first time, we report L. guyanensis from the central Amazon, L. braziliensis from the northern Pacific, and L. lainsoni from both the central Amazon and northern Pacific. Amazon cases had a longer median health-seeking delay in months (2.0, IQR 3.0) than Pacific cases (1.0, IQR 1.5). Prolonged health-seeking delay was associated with older age, Amerindian ethnicity, infection at lower altitudes, non-ulcerative lesions, and lesions on the lower limbs. CONCLUSIONS: In the Pacific region, health-seeking delay is relatively short and L. braziliensis prevalence remains low. Limited access to health care and stigma might explain the prolonged health-seeking delay in the Amazon. We recommend larger studies on the distribution of Leishmania species in Amazon CL cases and additional regional research into diagnostic test accuracy. Furthermore, the determinants of health-seeking delay in Ecuador should be investigated further. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08377-8.
format Online
Article
Text
id pubmed-10258766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102587662023-06-13 Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study Bezemer, Jacob M. Freire-Paspuel, Byron P. Schallig, Henk D. F. H. de Vries, Henry J.C. Calvopiña, Manuel BMC Infect Dis Research BACKGROUND: Cutaneous Leishmaniasis (CL) affects up to 5.000 people in Ecuador each year. L. guyanensis and L. braziliensis are the most common of the eight CL-causing Leishmania species. Earlier CL research concentrated on the easily accessible Pacific region. This study aims to describe the Leishmania species in Pacific and Amazon ecoregions, to analyze regional differences in CL patient clinical presentation, and to identify determinants of health-seeking delay. METHODS: All cases in this cross-sectional study were diagnosed using smear slide microscopy, PCR, or both. Cytochrome B gene sequencing was used to identify the causative Leishmania species in qPCR-positive samples. RESULTS: This study included 245 patients, with 154 (63%) infected in the Pacific region and 91 (37%) infected in the Amazon. Causative Leishmania species were identified in 135 patients (73% of qPCR positives). L. guyanensis was identified in 76% (102/135) of the samples and L. braziliensis in 19% (26/135). The Pacific region had a low prevalence of 6% (5/89) of L. braziliensis. For the first time, we report L. guyanensis from the central Amazon, L. braziliensis from the northern Pacific, and L. lainsoni from both the central Amazon and northern Pacific. Amazon cases had a longer median health-seeking delay in months (2.0, IQR 3.0) than Pacific cases (1.0, IQR 1.5). Prolonged health-seeking delay was associated with older age, Amerindian ethnicity, infection at lower altitudes, non-ulcerative lesions, and lesions on the lower limbs. CONCLUSIONS: In the Pacific region, health-seeking delay is relatively short and L. braziliensis prevalence remains low. Limited access to health care and stigma might explain the prolonged health-seeking delay in the Amazon. We recommend larger studies on the distribution of Leishmania species in Amazon CL cases and additional regional research into diagnostic test accuracy. Furthermore, the determinants of health-seeking delay in Ecuador should be investigated further. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08377-8. BioMed Central 2023-06-12 /pmc/articles/PMC10258766/ /pubmed/37308815 http://dx.doi.org/10.1186/s12879-023-08377-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bezemer, Jacob M.
Freire-Paspuel, Byron P.
Schallig, Henk D. F. H.
de Vries, Henry J.C.
Calvopiña, Manuel
Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title_full Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title_fullStr Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title_full_unstemmed Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title_short Leishmania species and clinical characteristics of Pacific and Amazon cutaneous leishmaniasis in Ecuador and determinants of health-seeking delay: a cross-sectional study
title_sort leishmania species and clinical characteristics of pacific and amazon cutaneous leishmaniasis in ecuador and determinants of health-seeking delay: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258766/
https://www.ncbi.nlm.nih.gov/pubmed/37308815
http://dx.doi.org/10.1186/s12879-023-08377-8
work_keys_str_mv AT bezemerjacobm leishmaniaspeciesandclinicalcharacteristicsofpacificandamazoncutaneousleishmaniasisinecuadoranddeterminantsofhealthseekingdelayacrosssectionalstudy
AT freirepaspuelbyronp leishmaniaspeciesandclinicalcharacteristicsofpacificandamazoncutaneousleishmaniasisinecuadoranddeterminantsofhealthseekingdelayacrosssectionalstudy
AT schallighenkdfh leishmaniaspeciesandclinicalcharacteristicsofpacificandamazoncutaneousleishmaniasisinecuadoranddeterminantsofhealthseekingdelayacrosssectionalstudy
AT devrieshenryjc leishmaniaspeciesandclinicalcharacteristicsofpacificandamazoncutaneousleishmaniasisinecuadoranddeterminantsofhealthseekingdelayacrosssectionalstudy
AT calvopinamanuel leishmaniaspeciesandclinicalcharacteristicsofpacificandamazoncutaneousleishmaniasisinecuadoranddeterminantsofhealthseekingdelayacrosssectionalstudy